Clopidogrel Bisulfate 75 mg

Indication : Clopidogrel Bisulfate is indicated for the prevention of atherothrombotic events in :
Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
Patients suffering from acute coronary syndrome :
• Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction). In combination with Acetylsalicylic acid (ASA).
• ST segment elevation acute myocardial infarction. In combination with ASA in medically treated patients eligible for thrombolytic therapy.

Composition : Each Clopidogrel Bisulfate Film coated tablet 75 mg contains Clopidogrel bisulfate equivalent to Clopidogrel 75 mg

Presentation : Clopidogrel Bisulfate Film coated tablet 75 mg
Box, 3 strips @ 10 film coated tablets

On medical prescription only.
Store below 30⁰C.
For more information, please check e-catalog